Beyfortus 50 mg/0.5 mL single-dose pre-filled syringe Images
Generic Name: nirsevimab
This medication has been identified as Beyfortus 50 mg/0.5 mL single-dose pre-filled syringe. It is supplied by AstraZeneca.
Beyfortus is used in the treatment of RSV Vaccination and Immunization; RSV and belongs to the drug class antiviral monoclonal antibodies. Beyfortus 50 mg/0.5 mL single-dose pre-filled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Beyfortus
- Generic Name
- nirsevimab
- Strength
- 50 mg/0.5 mL single-dose pre-filled syringe
- Availability
- Prescription only
- Drug Class
- Antiviral monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 49281-0575
See also:
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Abrysvo
Abrysvo is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
mRESVIA
mRESVIA is a vaccine used to immunize adults aged 60 years and older against lower respiratory ...
Palivizumab
Palivizumab is used for RSV, RSV Vaccination and Immunization
Rsv vaccine, pref a-pref b, recombinant
Respiratory Syncytial Virus (RSV) vaccines (Abrysvo, Arexvy, mResvia) are used to help reduce the ...
More about Beyfortus (nirsevimab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral monoclonal antibodies
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.